Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT05034432 · ClinicalTrials.gov registry record · Phase 4

The PIVATAL Study -Study of Ventricular Arrhythmia (VTA) Ablation in Left Ventricular Assist Device (LVAD) Patients

A Phase 4 study of Cardiomyopathies and Arrythmia, sponsored by University of Rochester.

Recruiting
Registry status
Phase 4
Development phase
100
Enrollment target
19
Study locations

NCT05034432 is a Phase 4 study of Cardiomyopathies and Arrythmia that is actively recruiting participants, run by University of Rochester. The registered enrollment target is 100 participants, below the 630-participant average among 17 other Cardiomyopathies trials with a reported enrollment target (84% lower). The trial reports 19 study locations across 15 states.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT05034432, a Phase 4 study of Cardiomyopathies and Arrythmia, is actively recruiting participants, sponsored by University of Rochester.

RECRUITING
Registry status
Phase 4
Development phase
100 participants
Enrollment target
19
Study locations

Study Summary

To investigate the effect of VTA ablation at the time of LVAD implant to see if it can reduce the incidence of VTA after surgery

Conditions Studied

Cardiomyopathies Arrythmia

Interventions

  • PROCEDURE Intra-Op Prophylactic VT ablation
  • OTHER Conventional Management

Study Locations (19)

California

  • UCLA Cardiac Arrthmia Center - Los Angeles
  • University of California San Francisco - San Francisco

Georgia

  • Piedmont Heart Institute - Atlanta
  • Emory University - Atlanta

New York

  • Columbia University Medical Center - New York
  • University of Rochester - Rochester

Pennsylvania

  • University of Pennsylvania - Philadelphia
  • UPMC - Pittsburgh

Arizona

  • Banner University Medical Center - Phoenix

District of Columbia

  • Medstar Washington Hospital Center - Washington D.C.

Indiana

  • Ascension St. Vincent Indianapolis - Indianapolis

Kentucky

  • Univedrsity of Louisville - Louisville

Trial Details

FieldValue
Enrollment Target 100 participants
Start Date 2022-05-27
Est. Completion 2027-06-30
Phase Phase 4

Sponsor

University of Rochester

636 total trials

Interested in This Trial?

Full Details on ClinicalTrials.gov ↗

What the Registry Record Tells You About NCT05034432

The ClinicalTrials.gov registry entry for NCT05034432 describes a study currently listed as recruiting, categorized as Phase 4. The registered enrollment target is 100 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 630-participant average among 17 other Cardiomyopathies trials with a reported enrollment target (84% lower). The listed sponsor is University of Rochester, which has 636 total studies on file at ClinicalTrials.gov.

The record links to 2 conditions, with Cardiomyopathies appearing as the primary indexed condition, and to 2 interventions - of which Intra-Op Prophylactic VT ablation is the first listed.

NCT05034432 reports 19 study locations spanning 15 distinct geographic areas - top geographies include California, Georgia, New York.

Frequently Asked Questions

What is clinical trial NCT05034432 about?

NCT05034432 is a clinical study titled "The PIVATAL Study -Study of Ventricular Arrhythmia (VTA) Ablation in Left Ventricular Assist Device (LVAD) Patients". To investigate the effect of VTA ablation at the time of LVAD implant to see if it can reduce the incidence of VTA after surgery

What is the current status of trial NCT05034432?

This trial is currently recruiting. It is a Phase 4 study. The enrollment target is 100 participants. The study started on 2022-05-27. Estimated completion is 2027-06-30.

What conditions does trial NCT05034432 study?

This clinical trial studies the following conditions: Cardiomyopathies, Arrythmia.

What interventions are being tested in trial NCT05034432?

The interventions under investigation include: Intra-Op Prophylactic VT ablation (PROCEDURE), Conventional Management (OTHER).

Who is sponsoring clinical trial NCT05034432?

This trial is sponsored by University of Rochester, which has 636 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT05034432 being conducted?

This trial has 19 study locations across Arizona, California, District of Columbia, Georgia, Indiana. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Learn More About Clinical Trials

Similar trials for Cardiomyopathies

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Explore more on PlainTrial

Cardiomyopathies

All registered trials for this condition

Arrythmia

All registered trials for this condition

Arizona

All trials with a study site in Arizona

Recruiting now

Find trials open to new participants near you

Rankings

Top sponsors, conditions, and phases

Read our methodology - how this data is sourced, computed, and verified.

Related

Browse all → | Rankings →
Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.